InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Gallagher Carol Giltner, 董事. Director active across 5 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 10 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €37k. Activity tracked since 8 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gallagher Carol Giltner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
7,828 股0Common StockSEC:0000905148-25-002142:0
150,000 股0Common StockSEC:0000905148-24-001057:0
7,555 股Common StockSEC:0001140361-24-003527:0
6,808 股@ US$58.75100.0% 占其流量Common StockSEC:0001628280-24-000312:0
179,020 股@ US$0.2236100.0% 占其流量Common StockSEC:0000905148-23-001457:0
标准退出：2024年2月11日 (T+90)
7,555 股0Common StockSEC:0001628280-23-023351:0
57,000 股0Common StockSEC:0001140361-23-028153:0
20,500 股0Common StockSEC:0001140361-22-024166:0
7,059 股0Common StockSEC:0001415889-21-003028:0
11,000 股0Common StockSEC:0001140361-21-020437:0
10 条申报中的 10 条
About Gallagher Carol Giltner
Director, Carol Giltner Gallagher has filed 10 disclosures in total. In the 10 recent filings we hold, the period runs from 2021-06-09 to 2025-06-12, with EUR 37445 of purchases and EUR 0 of sales, and the filings concern Atara Biotherapeutics, Inc., Mirati Therapeutics, Inc. and Certara, Inc.
